Skip to main content

Generate Biomedicines, Inc. insider trading

GENBNASDAQ
$13.69-0.11 (-0.80%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Feb 27, 2026 to Oct 2, 2026. Price (+8.2%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flow

Key players

  • MNMichael NallyChief Executive Officer2.251%of company
  • PMPioneering Medicines 02, LLC10% Owner1.2174%of company
  • SBStephane BancelDirector0.9232%of company
  • GGGevorg GrigoryanChief Technology Officer0.5142%of company
  • FAFrances ArnoldDirector0.3615%of company
  • JSJason SilversPresident & CFO0.0012%of company
  • JLJane L. MendilloDirector0.0012%of company
  • BGBeth GrousChief People Officer0.0002%of company
  • NHNutritional Health LTP Fund General Partner LLC10% OwnerNot reportedof company
  • FPFlagship Pioneering Fund VI, L.P.10% OwnerNot reportedof company

AI Activity Analysis

Premium
Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto
CompanyInsider / roleActionΔOwnAvg priceAmount
GENBFrances ArnoldDirectorOpen market sell$16K-0.2%$16.00$16KSep 1, 2026Sep 3, 2026
GENBMichael NallyChief Executive OfficerOpen market purchase$240K+0.7%$12.00$240KMar 4, 2026Mar 6, 2026
GENBBeth GrousChief People OfficerOpen market purchase$4.8KNot reported$16.00$4.8KMar 2, 2026Mar 2, 2026
GENBJason SilversPresident & CFOOpen market purchase$16K+200.0%$16.00$16KMar 2, 2026Mar 2, 2026
GENBJason SilversPresident & CFOOpen market purchase$8K+50.0%$16.00$8KMar 2, 2026Mar 2, 2026
GENBJason SilversPresident & CFOOpen market purchase$8K+50.0%$16.00$8KMar 2, 2026Mar 2, 2026
GENBNutritional Health LTP Fund General Partner LLC10% OwnerOpen market purchase$25M+2.6%$16.00$25MMar 2, 2026Mar 2, 2026
GENBNutritional Health LTP Fund General Partner LLC10% OwnerOpen market purchase$25M+2.6%$16.00$25MMar 2, 2026Mar 2, 2026
GENBNutritional Health LTP Fund General Partner LLC10% OwnerOpen market purchase$25M+2.6%$16.00$25MMar 2, 2026Mar 2, 2026
GENBJane L. MendilloDirectorOpen market purchase$24KNot reported$16.00$24KMar 2, 2026Mar 2, 2026
GENBFlagship Pioneering Fund VI, L.P.10% OwnerOpen market purchase$25M+2.6%$16.00$25MMar 2, 2026Mar 2, 2026
GENBFlagship Pioneering Fund VI, L.P.10% OwnerOpen market purchase$25M+2.6%$16.00$25MMar 2, 2026Mar 2, 2026
GENBFlagship Pioneering Fund VI, L.P.10% OwnerOpen market purchase$25M+2.6%$16.00$25MMar 2, 2026Mar 2, 2026
End of history · 13 transactions

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.